A shorter time interval between first and second dengue infections is associated with protection from clinical Illness in a school-based cohort in Thailand

Kathryn B. Anderson, Robert V. Gibbons, Derek A T Cummings, Ananda Nisalak, Sharone Green, Daniel H. Libraty, Richard G. Jarman, Anon Srikiatkhachorn, Mammen P. Mammen, Buddhari Darunee, In Kyu Yoon, Timothy P. Endy

Research output: Contribution to journalArticle

Abstract

Background. Despite the strong association between secondary dengue virus (DENV) infections and dengue hemorrhagic fever (DHF), the majority of secondary infections are subclinical or mild. The determinants of clinical severity remain unclear, though studies indicate a titer-dependent and time-dependent role of cross-protective anti-DENV antibodies.Methods. Data from 2 sequential prospective cohort studies were analyzed for subclinical and symptomatic DENV infections in schoolchildren in Kamphaeng Phet, Thailand (1998-2002 and 2004-2007). Children experiencing ≥1 DENV infection were selected as the population for analysis (contributing 2169 person-years of follow-up).Results. In total, 1696 children had ≥1 DENV infection detected during their enrollment; 268 experienced 2 or more infections. A shorter time interval between infections was associated with subclinical infection in children seronegative for DENV at enrollment, for whom a second-detected DENV infection is more likely to reflect a true second infection (average of 2.6 years between infections for DHF, 1.9 for DF, and 1.6 for subclinical infections).Conclusions. These findings support a pathogenesis model where cross-reactive antibodies wane from higher-titer, protective levels to lower-titer, detrimental levels. This is one of the first studies of human subjects to suggest a window of cross-protection following DENV infection since Sabin's challenge studies in the 1940s.

Original languageEnglish (US)
Pages (from-to)360-368
Number of pages9
JournalJournal of Infectious Diseases
Volume209
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Dengue Virus
Dengue
Thailand
Virus Diseases
Infection
Severe Dengue
Asymptomatic Infections
Cross Protection
Antibodies
Coinfection
Cohort Studies
Prospective Studies

Keywords

  • antibodies
  • dengue
  • epidemiology
  • immunity
  • pathogenesis
  • prospective cohort study

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy

Cite this

A shorter time interval between first and second dengue infections is associated with protection from clinical Illness in a school-based cohort in Thailand. / Anderson, Kathryn B.; Gibbons, Robert V.; Cummings, Derek A T; Nisalak, Ananda; Green, Sharone; Libraty, Daniel H.; Jarman, Richard G.; Srikiatkhachorn, Anon; Mammen, Mammen P.; Darunee, Buddhari; Yoon, In Kyu; Endy, Timothy P.

In: Journal of Infectious Diseases, Vol. 209, No. 3, 2014, p. 360-368.

Research output: Contribution to journalArticle

Anderson, KB, Gibbons, RV, Cummings, DAT, Nisalak, A, Green, S, Libraty, DH, Jarman, RG, Srikiatkhachorn, A, Mammen, MP, Darunee, B, Yoon, IK & Endy, TP 2014, 'A shorter time interval between first and second dengue infections is associated with protection from clinical Illness in a school-based cohort in Thailand', Journal of Infectious Diseases, vol. 209, no. 3, pp. 360-368. https://doi.org/10.1093/infdis/jit436
Anderson, Kathryn B. ; Gibbons, Robert V. ; Cummings, Derek A T ; Nisalak, Ananda ; Green, Sharone ; Libraty, Daniel H. ; Jarman, Richard G. ; Srikiatkhachorn, Anon ; Mammen, Mammen P. ; Darunee, Buddhari ; Yoon, In Kyu ; Endy, Timothy P. / A shorter time interval between first and second dengue infections is associated with protection from clinical Illness in a school-based cohort in Thailand. In: Journal of Infectious Diseases. 2014 ; Vol. 209, No. 3. pp. 360-368.
@article{eceeb7ce2449438da87dc04e63703e74,
title = "A shorter time interval between first and second dengue infections is associated with protection from clinical Illness in a school-based cohort in Thailand",
abstract = "Background. Despite the strong association between secondary dengue virus (DENV) infections and dengue hemorrhagic fever (DHF), the majority of secondary infections are subclinical or mild. The determinants of clinical severity remain unclear, though studies indicate a titer-dependent and time-dependent role of cross-protective anti-DENV antibodies.Methods. Data from 2 sequential prospective cohort studies were analyzed for subclinical and symptomatic DENV infections in schoolchildren in Kamphaeng Phet, Thailand (1998-2002 and 2004-2007). Children experiencing ≥1 DENV infection were selected as the population for analysis (contributing 2169 person-years of follow-up).Results. In total, 1696 children had ≥1 DENV infection detected during their enrollment; 268 experienced 2 or more infections. A shorter time interval between infections was associated with subclinical infection in children seronegative for DENV at enrollment, for whom a second-detected DENV infection is more likely to reflect a true second infection (average of 2.6 years between infections for DHF, 1.9 for DF, and 1.6 for subclinical infections).Conclusions. These findings support a pathogenesis model where cross-reactive antibodies wane from higher-titer, protective levels to lower-titer, detrimental levels. This is one of the first studies of human subjects to suggest a window of cross-protection following DENV infection since Sabin's challenge studies in the 1940s.",
keywords = "antibodies, dengue, epidemiology, immunity, pathogenesis, prospective cohort study",
author = "Anderson, {Kathryn B.} and Gibbons, {Robert V.} and Cummings, {Derek A T} and Ananda Nisalak and Sharone Green and Libraty, {Daniel H.} and Jarman, {Richard G.} and Anon Srikiatkhachorn and Mammen, {Mammen P.} and Buddhari Darunee and Yoon, {In Kyu} and Endy, {Timothy P.}",
year = "2014",
doi = "10.1093/infdis/jit436",
language = "English (US)",
volume = "209",
pages = "360--368",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - A shorter time interval between first and second dengue infections is associated with protection from clinical Illness in a school-based cohort in Thailand

AU - Anderson, Kathryn B.

AU - Gibbons, Robert V.

AU - Cummings, Derek A T

AU - Nisalak, Ananda

AU - Green, Sharone

AU - Libraty, Daniel H.

AU - Jarman, Richard G.

AU - Srikiatkhachorn, Anon

AU - Mammen, Mammen P.

AU - Darunee, Buddhari

AU - Yoon, In Kyu

AU - Endy, Timothy P.

PY - 2014

Y1 - 2014

N2 - Background. Despite the strong association between secondary dengue virus (DENV) infections and dengue hemorrhagic fever (DHF), the majority of secondary infections are subclinical or mild. The determinants of clinical severity remain unclear, though studies indicate a titer-dependent and time-dependent role of cross-protective anti-DENV antibodies.Methods. Data from 2 sequential prospective cohort studies were analyzed for subclinical and symptomatic DENV infections in schoolchildren in Kamphaeng Phet, Thailand (1998-2002 and 2004-2007). Children experiencing ≥1 DENV infection were selected as the population for analysis (contributing 2169 person-years of follow-up).Results. In total, 1696 children had ≥1 DENV infection detected during their enrollment; 268 experienced 2 or more infections. A shorter time interval between infections was associated with subclinical infection in children seronegative for DENV at enrollment, for whom a second-detected DENV infection is more likely to reflect a true second infection (average of 2.6 years between infections for DHF, 1.9 for DF, and 1.6 for subclinical infections).Conclusions. These findings support a pathogenesis model where cross-reactive antibodies wane from higher-titer, protective levels to lower-titer, detrimental levels. This is one of the first studies of human subjects to suggest a window of cross-protection following DENV infection since Sabin's challenge studies in the 1940s.

AB - Background. Despite the strong association between secondary dengue virus (DENV) infections and dengue hemorrhagic fever (DHF), the majority of secondary infections are subclinical or mild. The determinants of clinical severity remain unclear, though studies indicate a titer-dependent and time-dependent role of cross-protective anti-DENV antibodies.Methods. Data from 2 sequential prospective cohort studies were analyzed for subclinical and symptomatic DENV infections in schoolchildren in Kamphaeng Phet, Thailand (1998-2002 and 2004-2007). Children experiencing ≥1 DENV infection were selected as the population for analysis (contributing 2169 person-years of follow-up).Results. In total, 1696 children had ≥1 DENV infection detected during their enrollment; 268 experienced 2 or more infections. A shorter time interval between infections was associated with subclinical infection in children seronegative for DENV at enrollment, for whom a second-detected DENV infection is more likely to reflect a true second infection (average of 2.6 years between infections for DHF, 1.9 for DF, and 1.6 for subclinical infections).Conclusions. These findings support a pathogenesis model where cross-reactive antibodies wane from higher-titer, protective levels to lower-titer, detrimental levels. This is one of the first studies of human subjects to suggest a window of cross-protection following DENV infection since Sabin's challenge studies in the 1940s.

KW - antibodies

KW - dengue

KW - epidemiology

KW - immunity

KW - pathogenesis

KW - prospective cohort study

UR - http://www.scopus.com/inward/record.url?scp=84892640823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892640823&partnerID=8YFLogxK

U2 - 10.1093/infdis/jit436

DO - 10.1093/infdis/jit436

M3 - Article

VL - 209

SP - 360

EP - 368

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 3

ER -